DNLI — Denali Therapeutics Inc. stock price, charts and financials

QT59Denali Therapeutics Inc.

Denali Therapeutics Inc. (NASDAQ: DNLI) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
24.17
+1.02+4.41%
OverviewShort InterestFilings
DNLIQT59Denali Therapeutics Inc.·NASDAQ
24.17+4.41%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 28, 20268-KCurrent report
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 18, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
May 22, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEF 14ADefinitive proxy statement
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 21, 20263/AInitial statement of beneficial ownership (amended)
Apr 20, 20263Initial statement of beneficial ownership
Apr 03, 20268-KCurrent report
Mar 31, 20268-KCurrent report
#1 / 25 of 435
Page
▼
/ 18